Actinium Pharmaceuticals (ATNM) Q2 2026 Earnings

May 8Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.51
-0.39
-0.28
-0.16

Details

Expected EPS
-0.225
Actual EPS
-0.18
Surprise EPS
0.05
Surprise Percent
+20%

Description

⁨Actinium Pharmaceuticals⁩ (⁦ATNM⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts